A systematic review aiming to assess the prevalence of hypertension and its risk factors among the urban population in Southeast Asian countries was conducted. We performed database searches of PubMed and Web of Science and performed meta-analysis to determine the pooled prevalence estimate.
The aim of this review is to highlight the fundamental aspects of the diagnostic criteria, pathophysiology, and the treatment of the dyslipidemia in cardiometabolic syndrome.
Dyslipidemia and Cardiometabolic Syndrome Read More »
The research highlights the increased severity of COVID-19 in patients with diabetes mellitus, noting that hyperglycaemia may worsen outcomes by affecting immune responses. It suggests that insulin should be the primary treatment for managing acute glycaemia in these patients, while the effects of glucose-lowering medications like DPP4 inhibitors and SGLT2 inhibitors remain uncertain. Further investigation into the management of diabetes in the context of COVID-19 is needed.
COVID-19 and diabetes mellitus: from pathophysiology to clinical management Read More »
This study estimates the prevalence of central obesity in South Asian adults and examines gender differences in central obesity across cardiometabolic determinants.
Based on the main findings from the Systolic Blood Pressure Intervention Trial (SPRINT) and several recent
meta-analyses, the HT committee members of the Taiwan Society of Cardiology and the Taiwan Hypertension Society convened and finalized the revised BP targets for management of HT. We suggested a new systolic BP target to < 120mmHg for patients with coronary heart disease, chronic kidney disease with an eGFR of 20-60 ml/min/1.73 m2, and elderly patients aged 75 years, using unattended automated office BP measurement.
This site is only for use by healthcare professionals.
By continuing to view this site you are confirming that you are a healthcare professional.
